Gabapentin
Product Images NDC 76267-151

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 76267-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allied Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

600mg (600mg)

This is a medication label for Gabapentin Tablets, USP 600 mg. It contains instructions on dosage, storage, and safety precautions. Patients must keep medication away from children. The label also includes the National Drug Code (NDC) and information that pharmacists should dispense the medication with a Medication Guide. The label is manufactured for a company called Nse, but the text is too incomplete to provide further details.*

FDA Label Image

800mg (800mg)

Each tablet contains 800mg of Gabapentin, USP. It is used for the passage and persisting information. It is recommended to keep out of reach of children and store it in a controlled room temperature of 20°C to 25°C. The medication guide should be consulted. The product is manufactured by Nse and comes in a pack of 100 tablets. The rest of the text is not readable.*

FDA Label Image

Figure1.jpg (Figure1)

The text is a table or figure with percentages and labels indicating a study and treatments compared. A description of the content is not available due to the lack of information.*

FDA Label Image

Figure2.jpg (Figure2)

This appears to be a graph or chart with a y-axis labeled "difference (%)" ranging from -10% to 30% and an x-axis labeled "daily dose (mg)" ranging from 600 mg to 1800 mg. There are two lines plotted on the graph labeled "STUDY a" and "@sTuDY b". The difference between the two lines ranges from around 2% at 600 mg to around 22% at 1800 mg. There are no further details available to determine what the study or medication being evaluated is.*

FDA Label Image

Graph.jpg (Graph)

This is a chart displaying the mean pain score from a study. The dose of the medication being tested was 3600mg/day of gabapentin. The chart shows the pain scores at baseline, and at weeks 1, 2, 3, 4, 6, 7, and 8.*

FDA Label Image

Graph1.jpg (Graph1)

The text describes a graph showing the mean pain score over the course of a 7-week period. The graph includes a 3-week dose titration period and a 4-week fixed dose period. There are three treatment groups represented: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The mean pain score decreased over time in all three groups, but was consistently lowest in the gabapentin 2400 mg/day group. The statistical significance of the results is indicated by a p-value of less than .001.*

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.